Vincent Jarlier

Vincent Jarlier's AcademicInfluence.com Rankings

Vincent Jarlier

Chemistry

#4300

World Rank

#5370

Historical Rank

Organic Chemistry

#701

World Rank

#798

Historical Rank

chemistry Degrees

Vincent Jarlier

Biology

#11866

World Rank

#15295

Historical Rank

Molecular Biology

#1872

World Rank

#1901

Historical Rank

Biochemistry

#1987

World Rank

#2128

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Vincent Jarlier's Degrees

PhD Biochemistry Université Paris Cité

Why Is Vincent Jarlier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincent Jarlier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis (2005) (1894)
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. (1988) (1747)
Mycobacterial cell wall: structure and role in natural resistance to antibiotics. (1994) (555)
Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. (2008) (432)
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum (2013) (383)
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action (2012) (349)
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. (2018) (344)
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. (1992) (331)
The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. (2013) (323)
Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. (1995) (310)
Permeability barrier to hydrophilic solutes in Mycobacterium chelonei (1990) (297)
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. (2010) (294)
Society's failure to protect a precious resource: antibiotics (2011) (288)
Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing (2010) (280)
Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact (2004) (226)
Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity (2004) (219)
Porins in the cell wall of mycobacteria. (1992) (211)
Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes (2006) (193)
Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates (2010) (183)
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. (2011) (175)
Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis (2006) (171)
Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. (2010) (163)
Antimicrobial resistance: one world, one fight! (2015) (161)
Rapid Identification of Mycobacterial Whole Cells in Solid and Liquid Culture Media by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (2010) (157)
[Antibiogram Committee of the French Microbiology Society. Report 2000-2001]. (2000) (156)
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. (2010) (156)
Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum β-Lactamase Production by Enterobacteriaceae (2011) (153)
European recommendations for antimicrobial resistance surveillance. (2004) (149)
Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria (2006) (138)
Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration (2006) (136)
Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase (2010) (133)
Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa (1999) (132)
In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia (2001) (130)
Emergence and Spread in French Hospitals of Methicillin-Resistant Staphylococcus aureus with Increasing Susceptibility to Gentamicin and Other Antibiotics (1999) (129)
Surveillance of antimicrobial resistance--what, how and whither? (2001) (128)
Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance (2006) (125)
Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Clones Collected in France in 2006 and 2007 (2008) (122)
Characterization of New Mutations in Pyrazinamide-Resistant Strains of Mycobacterium tuberculosisand Identification of Conserved Regions Important for the Catalytic Activity of the Pyrazinamidase PncA (1999) (118)
Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria (1998) (115)
In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans (2006) (108)
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. (1999) (104)
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. (2005) (104)
Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002. (2006) (99)
Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. (2002) (97)
New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure (2012) (94)
Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A β-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France (2008) (92)
Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice (2002) (91)
Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae (1991) (90)
In vivo evaluation of antibiotic activity against Mycobacterium abscessus. (2014) (89)
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. (1994) (88)
French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance, 1992–2008: Positive Trends, But Perseverance Needed (2009) (85)
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis. (2009) (84)
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. (2009) (81)
Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. (2002) (81)
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. (2015) (80)
Permeability of the mycobacterial cell wall. (1991) (80)
Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis (2010) (79)
Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae (1989) (79)
Antibiotic Susceptibility Pattern ofMycobacterium marinum (2000) (79)
Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo (2003) (78)
First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis. (2006) (76)
Activities of New Macrolides and Fluoroquinolones against Mycobacterium ulcerans Infection in Mice (2001) (75)
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis. (2009) (75)
Activities of Several Antimicrobials againstMycobacterium ulcerans Infection in Mice (2000) (73)
Outbreak of Burkholderia cepacia Bacteremia in a Pediatric Hospital Due to Contamination of Lipid Emulsion Stoppers (2004) (73)
Outbreak of Nontuberculous Mycobacterial Subcutaneous Infections Related to Multiple Mesotherapy Injections (2009) (71)
National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. (2013) (71)
Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011 (2013) (70)
Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis (2012) (70)
Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model (2010) (67)
Antibacterial Resistance, Wayampis Amerindians, French Guyana (2004) (67)
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis (2011) (67)
Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. (2006) (67)
Characterization of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus Involved in Nosocomial Spread (1998) (66)
Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes (2012) (66)
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors (2017) (64)
Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital. (2005) (64)
Multidrug and extensively drug-resistant tuberculosis. (2017) (63)
Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem. (2001) (62)
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia (2013) (61)
Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. (2007) (61)
Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in Mice (2007) (60)
ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals (2017) (60)
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. (2011) (58)
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission. (2015) (58)
Healthcare-associated infections: think globally, act locally. (2008) (57)
Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis (2011) (57)
Identification of Mycobacterial Species by PCR Sequencing of Quinolone Resistance-Determining Regions of DNA Gyrase Genes (2003) (55)
Evaluation of the βLacta Test, a Rapid Test Detecting Resistance to Third-Generation Cephalosporins in Clinical Strains of Enterobacteriaceae (2013) (55)
Characteristics of human intestinal Escherichia coli with changing environments. (2008) (55)
Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis. (2001) (54)
Multilocus sequence typing scheme for the Mycobacterium abscessus complex. (2014) (53)
Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012 (2016) (53)
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. (2010) (53)
Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones (2006) (53)
Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012. (2014) (51)
Novel Class A β-Lactamase Sed-1 fromCitrobacter sedlakii: Genetic Diversity of β-Lactamases within the Citrobacter Genus (2001) (51)
Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer (2018) (50)
Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. (2004) (50)
Multidrug-resistant tuberculosis: eight years of surveillance in France (2003) (50)
The Pentapeptide Repeat Proteins MfpAMt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone Complex (2008) (49)
Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens. (2002) (48)
Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. (2006) (48)
Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study (2012) (46)
Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice (2006) (45)
Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study) (1996) (44)
Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. (2009) (44)
Extended-spectrum β-lactamases in long-term-care facilities (2008) (44)
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France. (1999) (44)
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae (1987) (43)
The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. (2008) (42)
A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. (2013) (42)
Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France (2015) (41)
Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem (1995) (41)
Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones (1995) (41)
Complete Nucleotide Sequence of the First KPC-2- and SHV-12-Encoding IncX Plasmid, pKpS90, from Klebsiella pneumoniae (2012) (40)
Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam (1988) (40)
Detection of Antibiotic Resistance in Leprosy Using GenoType LepraeDR, a Novel Ready-To-Use Molecular Test (2012) (38)
Surveillance of the current resistance of nosocomial pathogens to antibacterials (1997) (38)
Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals (1989) (37)
A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995–2004 (2007) (36)
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. (2012) (36)
Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. (1999) (36)
Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 beta-lactamase hydrolysing third-generation cephalosporins. (1998) (36)
Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones (1994) (35)
Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. (2017) (35)
Comparative potency of mecillinam and other β-lactam antibiotics against Escherichia coli strains producing different β-lactamases (2000) (35)
Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis (2014) (35)
DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis (2011) (34)
An intervention programme for the management of multidrug-resistant tuberculosis in France. (2007) (34)
Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. (1994) (34)
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria (2017) (33)
Prevention of Gram negative noscomial bronchopneumonia by intratracheal colistin in critically ill patients (1994) (33)
French Intensive Care Society, International congress – Réanimation 2016 (2016) (33)
Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE) (2012) (33)
Resistance to quinolones in mycobacteria. (1996) (32)
First Evaluation of Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Congo Revealed Misdetection of Fluoroquinolone Resistance by Line Probe Assay Due to a Double Substitution T80A-A90G in GyrA (2014) (31)
Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. (2008) (31)
Complete nucleotide sequence of the large conjugative pTC2 multireplicon plasmid encoding the VIM-1 metallo-β-lactamase. (2013) (31)
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. (1995) (31)
Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis (2014) (31)
Bactericidal and Sterilizing Activities of Several Orally Administered Combined Regimens against Mycobacterium ulcerans in Mice (2008) (30)
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis. (1998) (30)
Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. (2015) (29)
Are All the DNA Gyrase Mutations Found in Mycobacterium leprae Clinical Strains Involved in Resistance to Fluoroquinolones? (2007) (29)
First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs (2015) (29)
Evaluation of the New MB Redox System for Detection of Growth of Mycobacteria (1999) (28)
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice (2016) (26)
[Surveillance of multiresistant bacteria: justification, role of the laboratory, indicators, and recent French data]. (1998) (26)
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region (2021) (26)
Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. (2005) (26)
Incidence of tuberculous meningitis in France, 2000: a capture-recapture analysis. (2005) (26)
Expression and Purification of an Active Form of the Mycobacterium leprae DNA Gyrase and Its Inhibition by Quinolones (2007) (26)
Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris. (2012) (26)
Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 beta-lactamase hydrolysing expanded-spectrum cephalosporins. (1999) (26)
Increase in hospital-acquired bloodstream infections caused by extended spectrum β-lactamase-producing Escherichia coli in a large French teaching hospital (2009) (26)
Curing Mycobacterium ulcerans Infection in Mice with a Combination of Rifampin-Streptomycin or Rifampin-Amikacin (2006) (26)
Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers. (1998) (25)
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution. (2012) (25)
Broad-range PCR: past, present, or future of bacteriology? (2013) (25)
Extended-spectrum beta-lactamases in long-term-care facilities. (2008) (25)
Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model (2011) (24)
Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement. (2015) (24)
Mutagenesis in the α3α4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones (2008) (23)
Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1. (1999) (22)
Infection à Mycobacterium ulcerans (2000) (22)
Priority actions to fight antibiotic resistance: results of an international meeting (2012) (22)
Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need. (2009) (22)
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? (2017) (21)
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016 (2019) (21)
Antibiotic Susceptibility Pattern of Mycobacterium marinum (2000) (21)
Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain (2016) (21)
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98. (2001) (21)
Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015 (2018) (20)
Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates (2013) (20)
Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis (1996) (20)
Implementation of isolation precautions: role of a targeted information flyer. (2006) (19)
Efficient Intermittent Rifapentine-Moxifloxacin-Containing Short-Course Regimen for Treatment of Tuberculosis in Mice (2005) (19)
Endocarditis Due to Neisseria bacilliformis in a Patient with a Bicuspid Aortic Valve (2009) (18)
Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm (1993) (17)
Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis (2013) (17)
Erratum: Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin (Journal of Infectious Diseases (1994) 170 (479-83)) (1994) (17)
Superficial community‐acquired skin infections: prevalence of bacteria and antibiotic susceptibility in France (2009) (17)
Analysis of β-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid (1995) (17)
[Community-acquired cutaneous infections: causal role of some bacteria and sensitivity to antibiotics]. (2003) (17)
[Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections]. (2008) (15)
Mycobacterial Growth Indicator Tube Versus the Proportion Method on Löwenstein-Jensen Medium for Antibiotic Susceptibility Testing of Mycobacterium tuberculosis (2000) (15)
The Environmental Pathogen Mycobacterium ulcerans Grows in Amphibian Cells at Low Temperatures (2002) (15)
Corrigendum to ‘Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams’ [Clin Microbiol Infec 21 (2015) 649.e1–649.e10] (2015) (15)
Accumulation of carbapenemase-producing Gram-negative bacteria in a single patient linked to the acquisition of multiple carbapenemase producers and to the in vivo transfer of a plasmid encoding VIM-1. (2011) (15)
Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri. (2006) (15)
Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey (2019) (14)
Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital. (1984) (14)
Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France. (2012) (14)
Resistance of M. leprae to Quinolones: A Question of Relativity? (2013) (14)
Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulare (2014) (14)
Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. (2013) (14)
Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility. (1996) (14)
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France (2016) (14)
[Nosocomial influenza outbreak in a geriatrics department: Effectiveness of preventive measures]. (2006) (13)
Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam. (2008) (13)
Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in Mycobacteria (1997) (12)
Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents inPseudomonas aeruginosa (1995) (12)
Ruling out False-Positive Urinary Legionella pneumophila Serogroup 1 and Streptococcus pneumoniae Antigen Test Results by Heating Urine (2014) (12)
Bacterial resistance to antibiotics in France : a public health priority. (2000) (12)
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective. (2000) (12)
New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories (2015) (11)
Cloxacillin versus Pristinamycin for Superficial Pyodermas: A Randomized, Open-Label, Non-Inferiority Study (2005) (11)
Population Genomics of Mycobacterium leprae Reveals a New Genotype in Madagascar and the Comoros (2020) (11)
Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples. (1999) (11)
Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. (2016) (11)
Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018 (2021) (11)
Illustration of the Difficulty of Identifying Streptococcus equi Strains at the Subspecies Level through a Case of Endocarditis in an Immunocompetent Man (2013) (10)
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]. (2010) (10)
An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001–2002 (2006) (10)
Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. (2010) (10)
Comparison of a Semiautomated Commercial Repetitive-Sequence-Based PCR Method with Spoligotyping, 24-Locus Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat Typing, and Restriction Fragment Length Polymorphism-Based Analysis of IS6110 for Mycobacterium tuberculosis Typing (2014) (9)
Contribution of ParE Mutation and Efflux to Ciprofloxacin Resistance in Pseudomonas aeruginosa Clinical Isolates (2008) (9)
Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex (2015) (9)
The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS): A Worldwide Antimicrobial Web-Based Point Prevalence Survey (2015) (9)
Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study. (2018) (8)
[Listeria monocytogenes liver abscess. In a diabetic patient]. (1990) (8)
Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. (2018) (8)
Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysis (2019) (8)
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium. (2019) (8)
Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011. (2015) (8)
Aspects histopathologiques de l’infection à Mycobacterium marinum (2011) (8)
Multiple cerebral abscesses as a complication of Mycobacterium fortuitum infection. (2003) (8)
[Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin]. (1984) (7)
XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions. (2016) (7)
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. (2000) (7)
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses (2020) (7)
Daptomycin is not active against rapidly growing mycobacteria. (2010) (7)
Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice (2009) (7)
Crystal structure of the class D beta-lactamase OXA-13 in complex with meropenem (2001) (7)
Purification, crystallization and preliminary X-ray diffraction experiments on the breakage-reunion domain of the DNA gyrase from Mycobacterium tuberculosis. (2009) (7)
Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results (2020) (7)
[Relation between bacterial sensitivity to antibiotics and the consumption of antibiotics. 2 : Study carried out on Staphylococcus aureus at the Pitié-Salpêtrière Hospital from 1975 to 1980]. (1983) (7)
Evaluation of excreta management in a large French multi-hospital institution. (2015) (6)
Mycobacterium avium Complex Common-Source or Cross-Infection in AIDS Patients Attending the Same Day-Care Facility (1998) (6)
Could the DiversiLab® semi-automated repetitive-sequence-based PCR be an acceptable technique for typing isolates of Pseudomonas aeruginosa? An answer from our experience and a review of the literature. (2015) (6)
Detection by Genotype MTBDRsl test of complex resistance (2010) (6)
Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire). (2008) (6)
[New diagnostic tools for tuberculosis: the revolution is not over]. (2004) (6)
[Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study]. (1983) (5)
Two concomitant but unrelated cases of Pasteurella multocida infection, including meningitis secondary to pituitary adenoma microsurgery. (2010) (5)
[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Gene amplification tests]. (2004) (5)
[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis]. (1996) (5)
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. (1989) (5)
Whole-Genome Sequence of Mycobacterium abscessus Clinical Strain V06705 (2013) (5)
[Descriptive study of bacteremia in a geriatric hospital]. (2004) (5)
The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. (2016) (5)
Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa. (1994) (4)
Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient. (2015) (4)
Gentamicin-Susceptible or Gentamicin-Resistant Methicillin-Resistant Staphylococcus aureus A Case-Case Study (2006) (4)
Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate. (1998) (4)
Purification, Crystallization, and Preliminary X-Ray Diffraction Analysis of the Carbapenem-Hydrolyzing Class A β-Lactamase Sme-1 fromSerratia marcescens (1996) (4)
[Multi-resistant tuberculosis in France]. (2002) (3)
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin]. (1983) (3)
Evaluation of the Fluo-RAL Module for Detection of Tuberculous and Nontuberculous Acid-Fast Bacilli by Fluorescence Microscopy (2013) (3)
[Incidence and clinical characteristics of symptomatic urinary infections in a geriatric hospital]. (2007) (3)
A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples (2021) (3)
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics]. (1986) (3)
Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007 (2013) (3)
In vitro comparative activity of meropenem with 15 other antimicrobial agents against 1798 Pseudomonas aeruginosa isolates in a French multicenter study. (1999) (3)
[Evolution of the resistance of Streptococcus pneumoniae to erythromycin at the Pitié-Salpêtrière Hospital (1980-1984)]. (1986) (3)
Laser flare photometry in the therapeutic management of bacterial chronic pseudophakic endophthalmitis (2009) (3)
False-positive pneumococcal antigen test in a case of Enterococcus faecalis meningitis. (2013) (3)
[Histopathological study of Mycobacterium marinum infection]. (2011) (3)
Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis (2014) (3)
[Resistance to antituberculous drugs]. (2005) (3)
Growth on blood agar discriminates Mycobacterium avium and Mycobacterium intracellulare. (2003) (3)
Helicobacter cinaedi bacteraemia in an HIV-infected patient. (2015) (3)
[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections]. (1997) (3)
Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (−15C→T) (2015) (2)
Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, 2004 (2007) (2)
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor]. (1998) (2)
Purification, crystallization, and preliminary X-Ray diffraction analysis of the carbapenem-hydrolyzing class A beta-lactamase Sme-1 from Serratia marcescens. (1996) (2)
[Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae]. (1989) (2)
Genetic and structural insights into the dissemination pote ntial of the extremely-broad- 1 spectrum class A β-lactamase (EBSBL) KPC-2 identified in two strains of Escherichia 2 coli and Enterobacter cloacae isolated from the same patient in France. 3 (2008) (2)
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action (2012) (2)
Fully weekly antituberculosis regimen: a proof-of-concept study (2020) (2)
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group. (1995) (2)
Q203 containing fully intermittent oral regimens exhibited high sterilizing activity against Mycobacterium ulcerans in mice (2019) (2)
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen. (2018) (2)
Neither genotyping nor contact tracing allow correct understanding of multidrug-resistant tuberculosis transmission (2017) (2)
[Acute localized pneumopathies. Should macrolides always be prescribed initially?]. (1985) (1)
Regional trends in extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), E. coli SBLE and K. pneumonia SBLE between 2009 and 2013 (2015) (1)
O364 Multidrug-resistant bacteria surveillance, France, 2002–2005 (2007) (1)
Authors' CorrigendumEuropean recommendations for antimicrobial resistance surveillance (2004) (1)
Legionella wadsworthii pneumonia: gram stain usefulness. (2011) (1)
Draft Could the Diversilab ® semi-automated repetitive-sequence-based PCR be an acceptable technique for typing isolates of Pseudomonas aeruginosa ? An answer from our experience and a review of the literature (2015) (1)
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum (2013) (1)
[Relationship between bacterial sensitivity to antimicrobial agents and their consumption (author's transl)]. (1981) (1)
Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE) (2012) (1)
Good interpretation of the results of a diagnostic test. (2003) (1)
Bordetella bronchiseptica Pneumonia in a Woman with Lymphoma: A Case Report (2012) (1)
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]. (1983) (1)
[Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983]. (1984) (1)
Priority actions to fight antibiotic resistance: results of an international meeting (2012) (1)
Photo Quiz: A “Non-Gramable” Strain Isolated from a Cerebrospinal Fluid Sample (2016) (1)
[Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues]. (2015) (1)
Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region (2022) (1)
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections]. (2004) (1)
Nosocomial influenza outbreak in a geriatrics department (2008) (1)
[Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982]. (1984) (1)
[European Antibiotic Awareness Day: What is new in France?]. (2015) (1)
[Potential value of the amoxicillin-clavulanic acid combination in general medicine, gynecology-obstetrics and pediatrics departments]. (1984) (0)
Should Moxiﬂoxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model (cid:1) (2010) (0)
O477 Evaluation of a new version of the “RT-TB” triplex real-time PCR assay for the rapid diagnosis of Mycobacterium tuberculosis in clinical samples (2007) (0)
Antimicrobial resistance: one world, one fight! (2015) (0)
Crystal structure of the class D -lactamase OXA-13 (1998) (0)
[Generalized Mycobacterium avium complex infections in patients with HIV infection: a decreasing incidence]. (1997) (0)
Surveillance of multiresistant Mycobacterium tuberculosis in France in 1996 and 1997. (2000) (0)
Subject Index Vol. 210, 2005 (2005) (0)
Search for protein cross-reacting with OprD antibodies in Pseudomonas spp. and related species. (1994) (0)
Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer (2018) (0)
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa. (2018) (0)
Sensitivity to nine antibiotics of bacterial isolates from urinary tract infections in a urological ward: Therapeutic deductions (1983) (0)
[Evolution of susceptibility of aerobic gram-negative aerobic bacilli to quinolones and fluoroquinolones in a university hospital (1992-2000)]. (2002) (0)
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study (2018) (0)
Synthase C-Ring Structure the Diarylquinoline TMC 207 to the ATP Synthase : New Insights into the Binding of New Mutations in the Mycobacterial ATP (2012) (0)
P891 Mycobacterium leprae DNA gyrase:expression, purification, inhibition by quinolones and functional analysis of two mutant enzymes (2007) (0)
O034: Regional trends in enterobacteriaceae extended-spectrum beta-lactamase-producing (ESBLE) and methicillin-resistant staphylococcus aureus (MRSA) between 2007 and 2011 (2013) (0)
Crystal structure of the class A carbapenemase KPC-2 at 1.6 angstrom (2008) (0)
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. (1994) (0)
Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France—joint authors' response (2008) (0)
[Comparison of two methods of evaluation of gentamicin in man : bioassay and enzyme immunoassay (author's transl)]. (1981) (0)
Acquired resistance of mycobacterium tuberculosis to fluoroquinolones (1994) (0)
Crystal structure of the class D beta-lactamase OXA-13 (2001) (0)
Diagnostic bactériologique de la lèpre en France (2017) (0)
Activity of clarithromycin in infections, of normal mice with Mycobacterium ulcerans (1998) (0)
[Impact of the first year of the COVID-19 pandemic on the epidemiology of invasive infections (bacteremia) in the hospitals of the Assistance Publique - Hôpitaux de Paris]. (2022) (0)
[What are the new diagnostic tools for tuberculosis? What is their role in disease management and what are their indications?]. (2004) (0)
Contents Vol. 210, 2005 (2005) (0)
Regional trends in extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), E. coli SBLE and K. pneumonia SBLE between 2009 and 2013 (2015) (0)
Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012 (2016) (0)
Rapid communications A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union (2013) (0)
[Bacterial epidemiology and the importance of perioperative microbiology]. (2001) (0)
[Transurethral surgery and persistent urinary infection: effect of a single preoperative dose of cefuroxime]. (1987) (0)
[Mycobacterium ulcerans infection]. (2000) (0)
P2037 In vitro antibacterial activity of tigecycline against anaerobic hospital isolates;comparison of two methods in France: a multicentre study (2007) (0)
Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain (2016) (0)
Betalactamases chromosomiques. Induction et dérépression: signification clinique (1986) (0)
P2036 In vitro antibacterial activity of tigecycline against hospital isolates: comparison of two methods and proposal for zone diameter breakpoints in France: a multicentre study (2007) (0)
[BCG vaccination in France]. (1987) (0)
Tuberculosis: New tools for diagnosis (1997) (0)
[Discussion about the presentation: "Impact of the first year of the COVID-19 pandemic on the epidemiology of invasive infections (bacteremia) in the hospitals of the Assistance Publique - Hôpitaux de Paris"]. (2022) (0)
P1793 Emergence offiuoroquinolone resistance in the murine model of tuberculosis (2007) (0)
Crystal structure of the class A carbapenemase KPC-2 at 1.6 angstrom resolution (2008) (0)
Current epidemiology of Staphylococcus aureus with decreased susceptibility to glycopeptides (vancomycin and teicoplanin) in France (2000) (0)
Non-PCR-based amplification technique combined to DNA array hybridization to detect complex SNPs involved in antibiotic resistance (2009) (0)
[Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin]. (1990) (0)
pKpS90, from Klebsiella pneumoniae Plasmid, KPC-2- and SHV-12-Encoding IncX Complete Nucleotide Sequence of the First (2014) (0)
Answer to March 2016 Photo Quiz (2016) (0)
O034: Regional trends in enterobacteriaceae extended-spectrum beta-lactamase-producing (ESBLE) and methicillin-resistant staphylococcus aureus (MRSA) between 2007 and 2011 (2013) (0)
First Whole-Genome Sequence of a Clinical Isolate of Multidrug-Resistant Mycobacterium bovis BCG (2014) (0)
Interpreting Susceptibility Testing of Carbapenem Against Pseudomonas aeruginosa (2016) (0)
Structure of the imipenem-hydrolyzing beta-lactamase SME-1 (2001) (0)
Expression and Puriﬁcation of an Active Form of the Mycobacterium leprae DNA Gyrase and Its Inhibition by Quinolones (cid:1) (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincent Jarlier?

Vincent Jarlier is affiliated with the following schools:

Sorbonne University

Vincent Jarlier's Academic­Influence.com Rankings

Vincent Jarlier's Degrees

Why Is Vincent Jarlier Influential?

Vincent Jarlier's Published Works

Published Works

What Schools Are Affiliated With Vincent Jarlier?

Vincent Jarlier's AcademicInfluence.com Rankings